首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal HSP90AA1 Antibody

  • 中文名: HSP90AA1抗体
  • 别    名: EL52; HSPN; LAP2; HSP86; HSPC1; HSPCA; Hsp89; Hsp90; LAP-2; HSP89A; HSP90A; HSP90N; Hsp103; HSPCAL1; HSPCAL4; HEL-S-65p
货号: IPDX12749
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/500-1/1000 Human,Mouse,Rat

产品详情

AliasesEL52; HSPN; LAP2; HSP86; HSPC1; HSPCA; Hsp89; Hsp90; LAP-2; HSP89A; HSP90A; HSP90N; Hsp103; HSPCAL1; HSPCAL4; HEL-S-65p
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenSynthetic peptide of human HSP90AA1
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是3篇关于HSP90AA1抗体的代表性文献概览:

1. **文献名称**:HSP90α as a Biomarker for Early-Stage Lung Cancer Detection

**作者**:Smith et al. (2020)

**摘要**:通过开发高特异性HSP90AA1单克隆抗体,研究发现血清HSP90α水平在非小细胞肺癌患者中显著升高,验证了其作为无创液体活检标志物的潜力。

2. **文献名称**:Antibody Targeting HSP90AA1 Reduces Tau Aggregation in Alzheimer's Models

**作者**:Chen & Wang (2019)

**摘要**:研究利用新型HSP90AA1抗体抑制神经元中错误折叠蛋白的HSP90互作,显著降低Tau蛋白聚集,为神经退行性疾病治疗提供新策略。

3. **文献名称**:Comparative Analysis of Commercial HSP90AA1 Antibodies for Immunohistochemistry

**作者**:Garcia-Rodriguez et al. (2021)

**摘要**:系统评估了8种市售HSP90AA1抗体在乳腺癌组织中的表现,发现克隆号7F7在福尔马林固定标本中具有最优特异性和染色一致性。

注:上述文献信息为模拟示例,实际研究中建议通过PubMed或Web of Science检索最新文献,重点关注《Cancer Research》《Nature Communications》等期刊发表的相关论文。

背景信息

The HSP90AA1 antibody targets the heat shock protein 90 alpha family class A member 1 (HSP90AA1), a molecular chaperone critical for protein folding, stabilization, and activation under stress conditions. HSP90AA1. part of the HSP90 family, is an ATP-dependent chaperone that facilitates the conformational maturation of client proteins, including signaling kinases, transcription factors, and steroid hormone receptors. It plays a key role in cellular stress responses, oncogenesis, and neurodegenerative diseases. Dysregulation of HSP90AA1 is linked to cancer progression, as it stabilizes oncoproteins, making it a therapeutic target.

HSP90AA1 antibodies are widely used in research to study protein expression, localization, and interactions via techniques like Western blotting, immunohistochemistry, and immunoprecipitation. These antibodies help identify HSP90AA1 overexpression in tumors or its role in stress pathways. Monoclonal and polyclonal variants exist, often validated for specificity across species. Recent studies explore HSP90 inhibitors in cancer therapy, underscoring the antibody's diagnostic and experimental relevance. Its conserved structure, with an N-terminal ATP-binding domain and C-terminal dimerization motif, further supports functional analyses in diverse biological contexts.

客户数据及评论

折叠内容

大包装询价

×